$405.90
▼ -0.3% Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 2
● 23
▼ 0
Roper Technologies to present at Citi Technology Conference
Roper Technologies to present at Goldman Sachs Technology Conference
Roche Holding (SWX:ROP) Secures FDA Clearance For Alzheimer’s Blood Test
Overview
52-week range
$306
$525
46% of range
Avg surprise (last 2)
+1.1%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
25%
EM ±3.9% · $410 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $11.62 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $4.87 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $3.68 | — | — | — | — | financials |
| Mon Jul 21, 2025 | Jun/2025 | $4.87 | $4.82 | +1.0% | — | +1.3% | earnings |
| Mon Apr 28, 2025 | Mar/2025 | $4.78 | $4.73 | +1.1% | — | -1.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $3.40 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $3.12 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $3.54 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.11B | $2.10B | — | $2.02B | $1.94B | $1.88B | — | $1.76B |
| Cost of revenue | $639M | $642M | — | $614M | $598M | $589M | — | $543M |
| Gross profit | $1.47B | $1.45B | — | $1.40B | $1.35B | $1.29B | — | $1.22B |
| Operating income | $585M | $570M | — | $573M | $548M | $526M | — | $497M |
| Net income | $1.17B | $509M | — | $398M | $378M | $331M | — | $368M |
| EPS (diluted) | $11.62 | $4.87 | — | $3.68 | $3.49 | $3.06 | — | $3.40 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $365M | $383M | $297M | $320M | $242M | $373M | $188M | $270M |
| Inventory | $145M | $144M | $142M | $141M | $132M | $126M | $121M | $129M |
| Total current assets | $1.92B | $1.91B | $1.93B | $1.80B | $1.65B | $1.70B | $1.54B | $1.59B |
| Total assets | $35.17B | $34.55B | $34.58B | $34.58B | $33.22B | $31.42B | $31.33B | $31.55B |
| Long-term debt | $10.60B | $9.75B | $8.60B | $9.15B | $7.86B | $6.46B | $6.58B | $7.68B |
| Total liabilities | $16.47B | $15.73B | $14.70B | $14.59B | $13.59B | $12.20B | $12.47B | $13.04B |
| Total equity | $18.70B | $18.82B | $19.88B | $19.99B | $19.63B | $19.22B | $18.87B | $18.52B |